Kronos Bio, Inc. Appoints Marc Besman as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance

Kronos Bio, Inc. announced the appointment of Marc Besman Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance. Dr. Besman will be responsible for developing, implementing, and advancing global regulatory strategies for Kronos Bios portfolio. He will also ensure that the Company upholds the highest levels of clinical quality compliance.

Dr. Besman joins Kronos Bio from Coherus BioSciences where he served as Senior Vice President of Regulatory Affairs. While at Coherus BioSciences, he built out the regulatory affairs function and helped to advance the Companys oncology development programs. Previously, including at CytomX Therapeutics, Inc., Allergan, CTI Seattle and Baxter BioSciences, Dr. Besman held a series of leadership roles in regulatory affairs, development, and program management. Dr. Besman received a B.Sc.

Honours in Chemistry with Biochemistry from the University of Southampton (UK) and a M.Phil. and Ph.D. in Biochemistry from Yale University and he pursued a post-doctoral fellowship at the City of Hope, California.